CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase I Study of a p53MVA Vaccine in Combination With Pembrolizumab
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02432963
- Title field or adapter rule
- {'original_value': 'A Phase I Study of a p53MVA Vaccine in Combination With Pembrolizumab', 'source_field': 'protocolSection.identificationModule.officialTitle'}
- Ingested At
- 2026-10-31T23:27:23.131855+00:00
- Published At
- 2026-10-19T00:00:00+00:00
- Record Updated At
- 2026-10-19
- Source Retrieved At
- 2026-10-31T22:19:02.163121+00:00
- Timestamp Basis
- ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
- Date limitation
- ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Adult Solid Neoplasm", "Bladder Carcinoma", "Colon Carcinoma", "Estrogen Receptor Negative", "Head and Neck Squamous Cell Carcinoma", "Hepatocellular Carcinoma", "HER2/Neu Negative", "Melanoma", "Non-Small Cell Lung Carcinoma", "Pancreatic Carcinoma", "Progesterone Receptor Negative", "Rectal Carcinoma", "Renal Cell Carcinoma", "Soft Tissue Sarcoma", "Triple-Negative Breast Carcinoma", "TP53 Gene Mutation", "Unresectable Solid Neoplasm"]- protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-19", "type": "ACTUAL"}- protocolSection.identificationModule.nctId
"NCT02432963"- protocolSection.identificationModule.officialTitle
"A Phase I Study of a p53MVA Vaccine in Combination With Pembrolizumab"- protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct
null
Study condition terms
Interventions recorded in this study
- {'armGroupLabels': ['Treatment (p53MVA, pembrolizumab)'], 'description': 'Correlative studies', 'name': 'Laboratory Biomarker Analysis', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Treatment (p53MVA, pembrolizumab)'], 'description': 'Given SC', 'name': 'Modified Vaccinia Virus Ankara Vaccine Expressing p53', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Treatment (p53MVA, pembrolizumab)'], 'description': 'Given IV', 'name': 'Pembrolizumab', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
An intervention appearing in a study record does not establish an effect or an approved use.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.